Key Insights

Highlights

Success Rate

85% trial completion

Published Results

15 trials with published results (21%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

11.4%

8 terminated out of 70 trials

Success Rate

84.6%

-1.9% vs benchmark

Late-Stage Pipeline

34%

24 trials in Phase 3/4

Results Transparency

34%

15 of 44 completed with results

Key Signals

15 with results85% success

Data Visualizations

Phase Distribution

51Total
Not Applicable (18)
P 1 (4)
P 2 (5)
P 3 (19)
P 4 (5)

Trial Status

Completed44
Terminated8
Recruiting6
Not Yet Recruiting4
Withdrawn3
Unknown3

Trial Success Rate

84.6%

Benchmark: 86.5%

Based on 44 completed trials

Clinical Trials (70)

Showing 20 of 20 trials
NCT00260585Recruiting

Esophageal Cancer Risk Registry

NCT06984484Not ApplicableRecruitingPrimary

Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease

NCT07344935Not ApplicableCompletedPrimary

Evaluation of the Effectiveness of the Ezisurg Stapling (Ezi Endo Lite) During Laparoscopic Nissen Sleeve Gastrectomy

NCT02616302Phase 2RecruitingPrimary

A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

NCT07179250Not ApplicableNot Yet Recruiting

Effect of Breathing Training on Symptoms of Gastroesophageal Reflux Disease

NCT07174882Active Not Recruiting

Evaluation of the Clinical Course of NERD and Assessment of the Esophageal Mucosa Resistance

NCT07176221Not ApplicableNot Yet RecruitingPrimary

Endoscopic Cardial Constriction Ligation (ECCL) for Refractory GERD Using a Disposable Endoscope

NCT06862037Active Not RecruitingPrimary

Development of Machine Learning Models to Predict Postoperative GERD Symptom Resolution After Laparoscopic Nissen Fundoplication

NCT06974903CompletedPrimary

Retrospective Observational Study on GERD Management in General Hospitals in Korea

NCT06916130Phase 1Not Yet RecruitingPrimary

A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A

NCT05870163RecruitingPrimary

Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment

NCT06871163Not ApplicableNot Yet RecruitingPrimary

EFFICACY OF INSPIRATORY MUSCLE TRAINING ASSOCIATED WITH MANUAL TECHNIQUES IN INDIVIDUALS WITH GERD

NCT06564246Phase 4RecruitingPrimary

Clinical Study Evaluating The Role of Vonoprazan Versus Pantoprazole in Patients With Gastroesophageal Reflux Disease

NCT04506593Recruiting

Indiana University Gastrointestinal Motility Diagnosis Registry

NCT02471989Not ApplicableCompletedPrimary

FODMAPs and Refractory GERD

NCT05579587WithdrawnPrimary

Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients

NCT04660019Not ApplicableCompletedPrimary

Combined Scalp and Ear Acupuncture in Patients With Proton Pump Inhibitor- Dependent Gastroesophageal Reflux Disease

NCT01940185CompletedPrimary

A Post-Approval Study of the LINX® Reflux Management System

NCT04130659Not ApplicableUnknownPrimary

Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone

NCT00838526Phase 3CompletedPrimary

Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)

Scroll to load more

Research Network

Activity Timeline